Thiamylal

An overview of the barbiturate anesthetic Thiamylal

File:ThiamylalSVG.svg

Chemical structure of Thiamylal

Thiamylal is a barbiturate derivative used primarily as an anesthetic agent. It is known for its rapid onset and short duration of action, making it suitable for induction of anesthesia and short surgical procedures.

Pharmacology

Thiamylal acts on the central nervous system by enhancing the activity of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor. This action results in increased inhibitory neurotransmission, leading to sedation, hypnosis, and anesthesia.

Mechanism of Action

Thiamylal binds to the GABA_A receptor at a site distinct from the benzodiazepine binding site. This binding increases the duration of chloride ion channel opening, resulting in hyperpolarization of the neuron and decreased neuronal excitability.

Pharmacokinetics

Thiamylal is administered intravenously and is rapidly distributed throughout the body. It is metabolized in the liver and excreted primarily in the urine. The drug has a short half-life, which contributes to its brief duration of action.

Clinical Use

Thiamylal is used in the induction of general anesthesia and for short surgical procedures. It is also used in veterinary medicine for similar purposes. Due to its rapid onset, it is particularly useful in emergency situations where quick sedation is required.

Side Effects

Common side effects of thiamylal include respiratory depression, hypotension, and allergic reactions. Careful monitoring of vital signs is necessary during its administration.

Contraindications

Thiamylal is contraindicated in patients with a history of porphyria, severe asthma, or known hypersensitivity to barbiturates. It should be used with caution in patients with liver disease or renal impairment.

Related pages

• Barbiturate
• Anesthesia
• GABA_A receptor
• Sedative